Researching AXIUM Coiling Experience and Recanalization (RACER)
- Conditions
- Vascular DiseasesIntracranial Arterial DiseasesAneurysmsCerebrovascular Disorders
- Registration Number
- NCT00703794
- Lead Sponsor
- Medtronic Neurovascular Clinical Affairs
- Brief Summary
The data collected in this study will be used to support International Regulatory submissions. The study objective is to evaluate the continued safety and efficacy of the AXIUM Progressive Coil System.
This Device has been used clinically at approximately 150 Institutions under FDA 510(k) clearance since April 24, 2007. The device received CE authorization on June 30, 2007. Through December 2007, more than 1000 patients have been treated with the AXIUM Coils.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 119
- Patient or patient's legally authorized representative has signed and dated an Informed Consent Form
- Must be at least 18 years of age
- Aneurysm location, angio-architecture, morphology, or medical condition, is considered by the neurosurgical / interventional team to be at very high risk for management by traditional operative techniques, or aneurysm is considered to be inoperable
- Patient is willing to conduct follow-up visits
- Aneurysm was previously treated
- Patient has a cerebral aneurysm with a location, angioarchitecture or morphology that presents an unacceptable risk of morbidity due to the Study procedures
- Patient is participating in another clinical research Study
- Patient has a medical, social or psychological condition, which precludes the patient from receiving Study required treatment, evaluation, procedures and follow-up
- Female patient is pregnant or breast-feeding
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percent Occlusion Defined in protocol
- Secondary Outcome Measures
Name Time Method Morbidity/Mortality Defined in protocol
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (18)
Lac+Usc/Uscuh
🇺🇸Los Angeles, California, United States
Vascular and Interventional Specialists of Orange County, Inc. - St. Joseph Hospital of Orange
🇺🇸Orange, California, United States
Lee Memorial Health System
🇺🇸Fort Myers, Florida, United States
University of Miami - Jackson Memorial Hospital Systems
🇺🇸Miami, Florida, United States
Bayfront Medical Center
🇺🇸Saint Petersburg, Florida, United States
Tampa General Hospital
🇺🇸Tampa, Florida, United States
Neurologic & Orthopedic Hospital of Chicago (NOHC)
🇺🇸Chicago, Illinois, United States
Massachusetts General Hospital
🇺🇸Boston, Massachusetts, United States
University of Massachusetts Medical Center
🇺🇸Worcester, Massachusetts, United States
Abbott Northwestern
🇺🇸Minneapolis, Minnesota, United States
Scroll for more (8 remaining)Lac+Usc/Uscuh🇺🇸Los Angeles, California, United States